| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
(Stroke. 2000;31:2307.)
© 2000 American Heart Association, Inc.
Original Contributions |
From the Departments of Epidemiology (M.L.E., K.M.R.) and Biostatistics (D.J.C.), School of Public Health, University of North Carolina, Chapel Hill; Division of Epidemiology, School of Public Health, University of Minnesota, Minneapolis (D.K.A.); Mississippi Family Health Center, Jackson (R.S.); and Division of Hypertension, University of Mississippi Medical Center, Jackson (D.J.).
| Abstract |
|---|
|
|
|---|
MethodsIn 11 707 persons from the
Atherosclerosis Risk in Communities (ARIC) cohort who
were free of stroke and overt heart disease at baseline, Cox
proportional hazards analyses modeled the association between
OH at baseline and incident ischemic stroke over 7.9 years of
follow-up. OH was defined as a systolic blood pressure drop
20 mm Hg (systolic OH), a diastolic blood
pressure drop
10 mm Hg (diastolic OH), or a drop in
either (consensus OH) when a person changed from a supine to standing
position.
ResultsOH was predictive of ischemic stroke, even after adjustment for numerous stroke risk factors (consensus OH: hazard ratio, 2.0; 95% CI, 1.2 to 3.2). While the baseline characteristics associated with OH varied depending on the type of OH, all types of OH had a similar risk of stroke.
ConclusionsOH is an easily obtained measurement that may help to identify middle-aged persons at risk for stroke.
Key Words: cerebral infarction epidemiology hypotension, orthostatic prospective studies
| Introduction |
|---|
|
|
|---|
However, while numerous studies have documented the effects of BP and hypertension12 13 14 15 16 and use of antihypertensive medication17 18 19 20 on stroke, few epidemiological studies have evaluated OH as a risk factor for stroke.11 In cross-sectional studies, postural hypotension was associated with cerebrovascular disease, neurological symptoms, and/or transient ischemic attacks.9 21 22 One cross-sectional study that evaluated 3 definitions of OH suggested that each type of OH identifies a population subgroup characterized by different sets of risk factors.23 Longitudinal studies evaluating OH and cardiovascular disease24 25 or mortality26 27 28 29 include the Honolulu Heart Study, in which both systolic and diastolic OH were predictive of all-cause mortality,28 and a Finnish study in which only diastolic OH was associated with increased vascular mortality.29 OH is not even listed as a potential risk factor for stroke in several reviews,3 4 6 and most prospective investigations of stroke have not evaluated OH as a risk factor.15 16 30 31 32 Only 1 large longitudinal study, the Cardiovascular Health Study (CHS), was identified that included OH as a potential risk factor for stroke. In that study of persons aged 65 years and older, neurological symptoms, but not OH, were significantly associated with an increase in stroke incidence.14 Thus, whether OH is a significant predictor of stroke is unclear from the literature.
To our knowledge, the present study is the first prospective, population-based study of a middle-aged population to evaluate the association of OH and ischemic stroke. The study evaluates characteristics associated with types of OH and whether OH is a risk factor for incident ischemic stroke in a population without overt heart disease. While the main focus is on consensus OH, this study also evaluates whether a fall in systolic or diastolic BP conveys greater risk of stroke.
| Subjects and Methods |
|---|
|
|
|---|
Main Exposure
At the first clinical examination, BP measurements for
calculating postural change were taken with a Dinamap 1846 SX
oscillometric device. BP was measured at 30-second intervals for 2
minutes in both the supine (after 20 minutes of rest in the supine
position) and standing (beginning as the participants feet touched
the floor) positions. Postural change in BP was calculated as the
difference between the average supine and standing BPs (excluding the
first standing measurement to make the ARIC postural change measurement
similar to measurements used in other studies).34 Three
types of OH were evaluated: systolic OH (a systolic
postural drop
20 mm Hg irrespective of the
diastolic change), diastolic OH (a
diastolic postural drop
10 mm Hg irrespective of
the systolic change), and consensus OH (
20 mm Hg
systolic or
10 mm Hg diastolic postural BP
drop).35
Other Variables
Pulse pressure, mean arterial pressure, and ankle
brachial index (ABI) were determined and evaluated as covariates.
Brachial and ankle BP measurement procedures have been previously
described.36 The average brachial BP was used to define
pulse pressure (the difference between the systolic and
diastolic BPs) and mean arterial pressure (the
average diastolic BP plus one third of the pulse pressure).
ABI was calculated as the average systolic ankle pressure
divided by the average of the first 2 brachial systolic
BPs.
Baseline history of physician-diagnosed stroke, highest level of education (<high school, high school graduate, >high school), current smoking status (yes/no), current drinking status (yes/no), and level of alcohol consumption in grams per week (calculated from the usual number of drinks/glasses of beer, wine, and hard liquor consumed per week) were based on self-report. Prevalent myocardial infarction or coronary heart disease was defined as a history at baseline of physician diagnosis of a myocardial infarction, evidence of myocardial infarction from the examination ECG, or history of heart or arterial surgery, coronary artery bypass surgery, or balloon angioplasty. Use of medication for hypertension, congestive heart failure, arrhythmias, or diabetes was based on the self-report of medication use in the past 2 weeks for "high BP," "heart failure," "control of heart rhythm," or "diabetes or high blood sugar," respectively. Additionally, medications that were brought to the clinic were recorded and later categorized. For this study, specific antihypertensive medication types (diuretics, ß-blockers, angiotensin-converting enzyme inhibitors, calcium channel blockers, and other antihypertensive medications) were included in some models.
Eight-hour fasting blood was drawn from the vein in the antecubital
fossa and processed by a standardized protocol.33 White
blood cell counts (WBCs) were determined by Coulter counters. Diabetes
was defined as a nonfasting glucose
200 mg/dL (hexokinase method),
fasting glucose
126 mg/dL, self-report of a history of diabetes, or
use of diabetes medication in the prior 2 weeks.37
Fibrinogen was measured by the thrombin-time titration method, and von
Willebrand factor antigen was assayed by ELISA.38
Total cholesterol and HDL cholesterol were
measured by an enzymatic method. HDL was measured after precipitation
of non-HDL lipoproteins, and LDL cholesterol was
calculated.39 Body mass index (BMI) was calculated as the
measured weight/height2
(kg/m2). Carotid artery intima-media thickness
(IMT) was the average of 6 far-wall B-mode ultrasound measurements with
imputed estimates used for missing values.40 41 A sport
index, ranging from 1 (low) to 5 (high), characterized physical
activity.42 Left ventricular
hypertrophy (LVH) was determined by Cornell voltage
criteria for the resting ECG.43
Ascertainment of Incident Ischemic Stroke Events
This report is based on validated clinical events that were
identified through annual self-report or through ongoing community
surveillance. Hospital and autopsy records were used to classify
and validate strokes on the basis of the occurrence and duration of
neurological signs and symptoms, neuroimaging results, and other
diagnostic procedures and treatments, as previously
described.2 In this study, only events classified as
definite or probable ischemic (thrombotic and cardioembolic)
strokes were included. Events lasting <24 hours and events secondary
to trauma, neoplasm, hematologic abnormality, infection, or vasculitis
were not considered strokes. Among hospitalized persons with
neurological symptoms lasting
24 hours, 61% of the events were
validated as definite or probable strokes in a recent ARIC
study.2 Follow-up time was the time between baseline and
the first of the following events: ischemic stroke, death, last
contact, or December 31, 1996.
Statistical Methods
Exclusions from the present study included ethnicity other
than white or black, blacks from Minneapolis and Washington County
(n=103), age younger than 45 or older than 64 years at baseline
(n=158), missing brachial BP (n=14), positive or unknown history of
physician-diagnosed stroke at baseline (n=319), missing follow-up time
(n=1), positive or unknown history of myocardial infarction or
coronary heart disease at baseline (n=1007), atrial
fibrillation/flutter on ECG at baseline (n=22), use of medication for
congestive heart failure or arrhythmias at baseline (n=400),
and missing BP measurements that precluded the calculation of postural
BP change (n=2061, of whom 1502 underwent their baseline examination
before initiation of the postural change evaluation). Thus, 11 707
participants were included in the study.
Characteristics were determined for participants with and without OH at
baseline. Distributions of antihypertensive medication and antidiabetic
medication use by OH status were determined for those with hypertension
and diabetes, respectively. We used t tests, adjusted for
unequal variances, and
2 tests to test for
significant differences in baseline characteristics by OH status. To
assess the association between OH and incident ischemic
strokes, Cox proportional hazard models were evaluated after assessment
of the proportional hazard assumption for OH and each covariate. The ln
(-ln) survivor curves were assessed for categorical variables and
quartiles of continuous variables. When curves were not roughly
parallel, further evaluation was performed by including an interaction
term of the covariate with time, which was evaluated for significance
(P<0.05) and for whether inclusion resulted in a change of
20% of the hazard ratio for the main effect. When these criteria
were used, no significant departure from the proportional hazard
assumption was found. Consensus OH was tested for an association with
stroke in several models. Unadjusted analysis was followed by a
model including sociodemographic factors (age, sex, ethnicity,
education, and center). An intermediate model added potential risk
factors for OH and stroke (mean arterial pressure,
diabetes, hypertension medication use [yes/no]). Other potential risk
factors for stroke (current smoking, current drinking, level of alcohol
consumption, fibrinogen, HDL, LDL, IMT, sport index, ABI, pulse
pressure, LVH, von Willebrand factor, and WBC) were added to
the final model. Interaction terms between covariates and the main
exposure were tested in nested models and retained at an
of
0.05.
All sociodemographic covariates were kept in the final model. Other
covariates were retained if removing them resulted in a change in the
OH hazard ratio of
20% or if they reached an
of
0.05.
Diastolic and systolic OH were evaluated in the
unadjusted and final model. The final model evaluating consensus OH was
repeated after (1) substitution of specific BP medications for general
antihypertensive medication use; (2) addition of diabetic medication
use; and (3) stratification by use of medications (antihypertensive and
diabetic).
| Results |
|---|
|
|
|---|
|
Longitudinal Results
Within the study population, there were 178 incident
ischemic strokes (1.5%) over 7.9 years of follow-up. The
incidence of ischemic strokes was significantly higher among
those with OH relative to those without OH regardless of the type of OH
(Table 2
). Among persons with stroke,
follow-up time was slightly less for those with OH than for those
without OH, but the values did not vary significantly. In the
unadjusted model, the hazard of stroke for participants with OH was 4
times that of participants who did not have OH (Table 3
). The hazard ratio was attenuated after
we adjusted for sociodemographic factors (age, sex, ethnicity, center,
and education) and further attenuated after we controlled for mean
arterial pressure, diabetes, and antihypertensive
medication use. In the final model, which included additional
covariates for current smoking, ABI, IMT, and WBC, OH remained a
significant predictor of stroke, with an associated hazard ratio of 2.
Systolic and diastolic OH had similar adjusted
risks of stroke, with hazard ratios of 2.1 (95% CI,1.3 to 3.4) and 2.2
(95% CI, 1.1 to 4.6), respectively. Specific classes of
antihypertensive medications were substituted (and retained regardless
of significance) for the covariate "use of any antihypertensive
medication" in the final model for consensus OH. The hazard ratio
changed little. Addition of a covariate for use of diabetic medication
had little effect on the hazard ratio. Age significantly modified the
relationship between OH and stroke (P<0.05). Therefore, the
hazard ratios for 3 ages were estimated by using interaction terms
between OH and age as a continuous variable centered at 45, 55, and
64. Age-specific hazard ratios were found to be lower at older ages
(Table 3
). After stratification for antihypertensive and
diabetic medication use, the risk of stroke for persons with OH
compared with persons without OH was increased in all medication use
strata (hazard ratio >1) but was somewhat stronger overall for those
on medication (Table 3
).
|
|
| Discussion |
|---|
|
|
|---|
Potential Mechanisms or Risk Factors for OH
Normally, the immediate rapid fluctuations in BP that occur within
seconds after standing are followed within 30 seconds to 20 minutes by
a stabilized BP.44 45 Fluid shifts and the effects of
gravity on standing cause low carotid baroreceptor pressure, resulting
in catecholamine release with peripheral
vasoconstriction and increased heart rate that normally produces
pressure stabilization. Malfunction in one or more of these normal
processes has been implicated in OH.46 47 48 49 Since primary
dysfunction of the heart, such as heart failure or arrhythmias,
may cause OH46 47 50 and since significant heart disease
is strongly associated with stroke,14 15 31 the
present study has eliminated participants with evidence of overt
heart disease. A number of other mechanisms have been proposed for OH,
and 1 study suggested that different types of OH would identify
different sets of risk.23 Mechanisms for OH other than
cardiac dysfunction include autonomic nervous system
dysfunction,46 47 49 51 52 reduced effective intravascular
volume, and impaired baroreceptor function.46 47 49 52
Aging, diabetes, medication, alcoholism, and other neurological
diseases have been implicated in autonomic dysfunction and with
OH.47 In the total ARIC population, the decile of largest
systolic pressure drop was previously shown to be associated
with older age and concomitant disease.36 The present
study also found that both systolic and diastolic
OH were associated with increased age, prevalence of diabetes, and
medication use among diabetics. Drinkers with systolic or
diastolic OH had higher alcohol consumption than those
without OH (approximately 3 more drinks per week), but the difference
was not statistically significant. Decreased arterial wall
compliance in hypertension and arteriosclerosis is
thought to contribute to OH by diminishing baroreceptor responsiveness
or by allowing pooling of blood in the peripheral vascular
system.29 53 In the present study the presence of
higher IMT (a marker of subclinical atherosclerosis)
and the presence of hypertension were associated with both
systolic and diastolic OH, while low ABI (a marker
of lower extremity arterial stenosis) was
associated with systolic but not diastolic OH.
Other cardiovascular risk factors significantly
associated with 1 but not both types of OH included ethnicity, sex,
diastolic BP, LVH, smoking status, HDL, and BMI. Many more
participants had systolic than diastolic OH.
Therefore, the study indicates that the type of OH studied can
potentially identify different populations with somewhat different risk
factor associations, as suggested previously.23
OH as a Risk Factor for Ischemic Stroke
Few prospective studies have evaluated the association of OH with
stroke, although several have evaluated the association between OH and
various vascular outcomes24 25 29 or all-cause
mortality.26 27 28 In 2 studies, OH was related to
coronary heart disease24 and all-cause
mortality28 independently of other risk factors. The CHS,
which examined the association of OH with stroke, found that several
neurological symptoms were associated with incident stroke but that OH
was not.14 The most likely reason for the apparent
discrepancy between the present study and CHS is age differences in
the population. CHS participants were aged 65 years and older. In the
present study the hazard associated with OH was lower with older
age, and therefore there was no increased risk of stroke associated
with OH at age 64 years in the overall population. Several other risk
factors for stroke, such as smoking, transient ischemic
attacks, hypertension, and elevated cholesterol, are
reported to be stronger in younger persons.15 As an
outcome becomes more frequent with age, it is not surprising to find a
negative interaction on a multiplicative scale.
OH might predict stroke for a number of reasons. First, the pressure fall itself may contribute to decreased cerebral perfusion, directly or indirectly. There is evidence that OH may be associated directly with decreased cerebral perfusion,10 and other studies indicate that very low BP in general may have negative effects.14 20 54 One study found significantly lower cerebral blood flow in patients with low diastolic BP.54 At least 2 studies have suggested that there is an increase in mortality or stroke risk for persons on antihypertensive medication in the lowest stratum of BP compared with persons with more moderate BP.14 20 The present study suggests that OH is associated with a higher risk of stroke among those with lower BP, but the difference across pressures was not statistically significant (data not shown). OH could act indirectly as well. Investigators have suggested that the autoregulation of the cerebrovascular blood flow that occurs in response to peripheral pressures could exacerbate the decrease in cerebral blood flow associated with hypotension if hemodynamic instability develops.55 Given that OH has been associated with myocardial injury,24 postural hypotension may contribute to cerebral hypoperfusion through myocardial ischemia and concomitant hemodynamic instability.
There are other potential reasons for the OH/stroke association. In the present study, adjustment for sociodemographic and numerous stroke risk factors removed approximately one half of the stroke risk associated with OH. Thus, at least part of the unadjusted stroke risk is because OH is a marker for, or is in the causal pathway of, these other risk factors. However, adjustment for risk factors did not remove all of the association between OH and incident stroke. Reasons for the continued association between OH and stroke (other than causality) may be that OH is a marker of severity for measured stroke risk factors or is a marker for unmeasured risk factors, such as cardiac dysfunction, general frailty, or subclinical cerebrovascular disease. Persons with overt heart disease were removed from the study, but OH may be an indicator for other cardiac impairment such as left ventricular dysfunction or arterial stiffness, which were not directly measured. The association could remain because OH is a marker of general frailty. The Honolulu Heart Program identified an association between OH and several markers of frailty but found that OH continued to be associated with all-cause mortality even after controlling for those measures.28 Finally, the association could remain because of other residual confounding. Thus, the fact that OH is an independent risk factor for stroke in the present study does not exclude the possibility that OH acts as a measure of disease severity, frailty, or cardiac dysfunction or is in the causal pathway of these other risk factors.
In cross-sectional studies, medications for treating hypertension and diabetes have been associated with OH,21 56 57 and therefore the present findings might be attributed to medication. However, since OH remained predictive of stroke after stratification for use of medication to treat hypertension and diabetes, it is unlikely that the association between OH and stroke occurred because of medication use alone. Overall results suggested a nonsignificantly higher risk among persons treated for either diabetes or hypertension compared with those not on medication. Whether the differences in risk were because the medications interacted in some way with OH to contribute to stroke, because treatment indicated more severe disease, or merely because of chance cannot be determined from the present data.
Study Strengths and Limitations
Study strengths include its prospective design, the standardized
procedures used, and the population basis for the original sample.
Additionally, the use of average supine and standing BPs rather than
the first supine BP and a single standing pressure avoids 2 potential
problems. One is the overestimation of the prevalence of OH that may
occur when the first supine pressure is used.58 Another is
the potential for missing OH if a single standing pressure is used
since measuring standing pressure at 1 versus 3 minutes may identify
different individuals.59 Using an average standing
pressure should identify all persons with significant pressure drop of
more than fleeting duration. However, the fact that we did not
specifically time postural pressure change prevents us from evaluating
whether there were differences in persons who had postural pressure
changes at 1 and 3 minutes. More than 2000 participants had missing
postural change data. Since induction and clinic date assignment were
random, participants missing data because their examinations were
before institution of the postural change protocol should not have
contributed to bias in the study. Another limitation was that persons
with nonfatal events who were not hospitalized and persons who died but
were not autopsied could not be included as stroke cases because they
could not be validated. Nonhospitalized stroke may range from 3% to
28%.1
Our study indicates that, as previously suggested, different types of OH may identify different populations with somewhat different characteristics.23 However, over a mean follow-up of 7.9 years, each type of OH was predictive of ischemic stroke even after adjustment for numerous accepted stroke risk factors. The ease and minimal expense of postural change measurement may make OH a useful tool in detecting a population at increased risk of stroke. Additional clinical and epidemiological studies are needed to further our understanding of the risk posed by OH and the potential benefit of treating it.
| Acknowledgments |
|---|
| Footnotes |
|---|
Received May 23, 2000; revision received July 5, 2000; accepted July 5, 2000.
| References |
|---|
|
|
|---|
2.
Rosamond WD, Folsom AR, Chambless LE, Wang C-H,
McGovern PG, Howard G, Copper LS, Shahar E. Stroke incidence and
survival among middle-aged adults: 9-year follow-up of the
Atherosclerosis Risk in Communities (ARIC) cohort.
Stroke. 1999;30:736743.
3.
Helgason CM, Wolf PA. American Heart Association
Prevention Conference IV: prevention and rehabilitation of stroke,
executive summary. Circulation. 1997;96:701707.
4.
Khaw K-T. Epidemiology of
stroke. J Neurol Neurosurg Psychiatry. 1996;61:333338.
5.
Wolf PA, Lewis A. Conner lecture: Contributions of
epidemiology to the prevention of stroke.
Circulation. 1993;88:24712478.
6.
Gorelick PB. Stroke prevention. Arch
Neurol. 1995;52:347355.
7. Naschitz JE, Mazov I, Eridzhanyan L, Keren D, Rennert HS, Yeshurun D. Hypotensive reactions on passive head-up tilt testing of hypertensive patients. J Hum Hypertens. 1996;10:369373.[Medline] [Order article via Infotrieve]
8.
Roman GC. Senile dementia of the Binswanger type: a
vascular form of dementia in the elderly. JAMA. 1987;258:17821788.
9.
Ruff RL, Talman WT, Petito F. Transient
ischemic attacks associated with hypotension in hypertensive
patients with carotid artery stenosis. Stroke. 1981;12:353355.
10.
Hayashida K, Nishiooeda Y, Hirose Y, Ishida Y,
Nishimura T. Maladaptation of vascular response in frontal area of
patients with orthostatic hypotension. J Nucl
Med. 1996;37:14.
11.
Dobkin BH. Orthostatic hypotension as a
risk factor for symptomatic occlusive cerebrovascular
disease. Neurology. 1989;39:3034.
12.
Kannel WB, Wolf PA, Verter J, McNamara PM.
Epidemiologic assessment of the role of blood pressure in stroke: the
Framingham Study. JAMA. 1970;214:301310.
13.
Kannel WB. Blood pressure as a
cardiovascular risk factor. JAMA. 1996;275:15711576.
14.
Manolio TA, Kronmal RA, Burke GL, OLeary DH, Price
TR. Short-term predictors of incident stroke in older adults.
Stroke. 1996;27:14791486.
15.
Whisnant JP, Wiebers DO, OFallon WM, Sicks JD, Frye
RL. A population-based model of risk factors for ischemic
stroke: Rochester, Minnesota. Neurology. 1996;47:14201428.
16. Welin L, Svardsudd K, Wilhelmsen L, Larsson B, Tibblin G. Analysis of risk factors for stroke in a cohort of men born in 1913. N Engl J Med. 1987;317:521526.[Abstract]
17.
HDFP Cooperative Group. Five-year findings of the
Hypertension Detection and Follow-up Program. JAMA. 1982;247:633638.
18.
Klungel OH, Kaplan RC, Heckbert SR, Smith NL, Lemaitre
RN, Longstreth WT, Leufkens HGM, de Boer A, Psaty BM. Control of blood
pressure and risk of stroke among pharmacologically treated
hypertensive patients. Stroke. 2000;31:420424.
19.
SHEP Cooperative Research Group. Prevention of stroke
by antihypertensive drug treatment in older persons with isolated
systolic hypertension. JAMA. 1991;265:32553264.
20.
Voko Z, Bots ML, Hofman A, Koudstaal PJ, Witteman JCM,
Breteler MMB. J-shaped relation between blood pressure and stroke in
treated hypertensives. Hypertension. 1999;34:11811185.
21.
Mader SL, Josephson KR, Rubenstein LZ. Low prevalence
of postural hypotension among community-dwelling elderly.
JAMA. 1987;258:15111514.
22.
Wu J-S, Lu F-H, Yang Y-C, Chang C-J. Postural
hypotension and postural dizziness in patients with
non-insulin-dependent diabetes. Arch Intern Med. 1999;159:13501356.
23.
Alli C, Avanzini F, Bettelli G, Colombo F, Corso R, Di
Tullio M, Marchioli R, Mariotti G, Radice M, Taioli E, Terzian E,
Tognoni G, Zussino A. Prevalence and variability of
orthostatic hypotension in the elderly: results of the
"Italian study on blood pressure in the elderly (SPAA)." Eur
Heart J. 1992;13:178182.
24. Rose K, Tyroler HA, Nardo CJ, Arnett D, Light K, Rosamond W, Sharrett AR, Szklo M. Orthostatic hypotension and the incidence of coronary heart disease: the Atherosclerosis Risk in Communities (ARIC) Study. Am J Hypertens. 2000;13:571578.[Medline] [Order article via Infotrieve]
25.
Sparrow D, Tifft CP, Rosner B, Weiss ST. Postural
changes in diastolic blood pressure and the risk of
myocardial infarction: the Normative Aging Study.
Circulation. 1984;70:533537.
26. Atkins D, Hanusa B, Sefcik T, Kapoor W. Syncope and orthostatic hypotension. Am J Med. 1991;91:179185.[Medline] [Order article via Infotrieve]
27.
Davis BR, Langford HG, Blaufox MD, Curb JD, Polk BF,
Shulman NB. The association of postural changes in systolic
blood pressure and mortality in persons with hypertension: the
Hypertension Detection and Follow-up Program experience.
Circulation. 1987;75:340346.
28.
Masaki KH, Schatz IJ, Burchfiel CM, Sharp DS, Chiu D,
Foley D, Curb JD. Orthostatic hypotension predicts
mortality in elderly men: the Honolulu Heart Program.
Circulation. 1998;98:22902295.
29.
Raiha I, Luutonen S, Piha J, Seppanen A, Toikka T,
Sourander L. Prevalence, predisposing factors, and prognostic
importance of postural hypotension. Arch Intern Med. 1995;155:930935.
30. Nielsen WB, Lindenstrom E, Vestbo J, Jensen GB. Is diastolic hypertension an independent risk factor for stroke in the presence of normal systolic blood pressure in the middle-aged and elderly? Am J Hypertens. 1997;10:634639.[Medline] [Order article via Infotrieve]
31. Neaton JD, Wentworth DN, Cutler J, Stamler J, Kuller L. Risk factors for death from different types of stroke. Ann Epidemiol. 1993;3:493499.[Medline] [Order article via Infotrieve]
32.
Rastenyte D, Tuomilehto J, Domarkiene S, Cepaitis Z,
Reklaitiene R. Risk factors for death from stroke in middle-aged
Lithuanian men: results from a 20-year prospective study.
Stroke. 1996;27:672676.
33.
ARIC Investigators. The Atherosclerosis
Risk in Communities (ARIC) Study: design and objectives. Am
J Epidemiol. 1989;129:687702.
34. Mader SL, Palmer RM, Rubenstein LZ. Effect of timing and number of baseline blood pressure determinations on postural blood pressure response. J Am Geriatr Soc. 1989;37:444446.[Medline] [Order article via Infotrieve]
35.
Consensus Committee of the American Autonomic Society
and the American Academy of Neurology. Consensus statement on the
definition of orthostatic hypotension, pure autonomic
failure, and multiple system atrophy. Neurology. 1996;46:1470.
36.
Nardo CJ, Chambless LE, Light KC, Rosamond WD, Sharrett
AR, Tell GS, Heiss G. Descriptive epidemiology
of blood pressure response to change in body position: the ARIC Study.
Hypertension. 1999;33:11231129.
37. Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Diabetes Care. 1998;21:S5S19.
38. Papp AC, Hatzakis H, Bracey A, Wu KK. ARIC hemostasis study, I: development of a blood collection and processing system suitable for multicenter hemostatic studies. Thromb Haemost. 1989;61:1519.[Medline] [Order article via Infotrieve]
39. Friedewald WT, Levy RI, Fredrickson DS. Estimation of the concentration of the low-density lipoprotein cholesterol in plasma, without the use of the preparative ultracentrifuge. Clin Chem. 1972;18:499502.[Abstract]
40. Riley WA, Evans G, Barnes RW, Chambless LE, Bond MG, Heiss G. High-resolution B-mode ultrasound reading methods in the Atherosclerosis Risk in Communities (ARIC) cohort. J Neuroimag. 1991;1:168172.[Medline] [Order article via Infotrieve]
41.
Chambless LE, Folsom AR, Clegg LX, Sharrett AR, Shahar
E, Nieto FJ, Rosamond WD, Evans G. Carotid wall thickness is predictive
of incident clinical stroke: the Atherosclerosis Risk
in Communities (ARIC) Study. Am J Epidemiol. 2000;151:478487.
42.
Baecke JAH, Burema J, Frijters JER. A short
questionnaire for the measurement of habitual physical activity in
epidemiological studies. Am J Clin Nutr. 1982;36:936942.
43. Crow RS, Prineas RJ, Rautaharju P, Hannan P, Liebson PR. Relation between electrocardiography and echocardiography for left ventricular mass in mild systemic hypertension (results from Treatment of Mild Hypertension Study). Am J Cardiol. 1995;75:12331238.[Medline] [Order article via Infotrieve]
44. Smith JJ, Porth CM, Erickson M. Hemodynamic response to the upright posture. Clin Pharmacol. 1994;34:375386.
45. Borst C, van Brederode JFM, Wieling W, van Montfrans GA, Dunning AJ. Mechanisms of initial blood pressure response to postural change. Clin Sci. 1984;67:321327.[Medline] [Order article via Infotrieve]
46. Hollister AS. Orthostatic hypotension: causes, evaluation, and management. West J Med. 1992;157:652657.[Medline] [Order article via Infotrieve]
47. Mathias CJ. Orthostatic hypotension: causes, mechanisms, and influencing factors. Neurology. 1995;45(suppl 5):S6S11.
48. Mader SL. Orthostatic hypotension. Med Clin North Am. 1989;73:13371349.[Medline] [Order article via Infotrieve]
49.
Schatz IJ. Orthostatic hypotension:
functional and neurogenic causes. Arch Intern Med. 1984;144:773777.
50. Lipsitz LA, Jonsson PV, Marks BL, Parker JA, Royal HD, Wei JY. Reduced supine cardiac volumes and diastolic filling rates in elderly patients with chronic medical conditions: implications for postural blood pressure homeostasis. J Am Geriatr Soc. 1990;38:103107.[Medline] [Order article via Infotrieve]
51. Ward C, Kenny RA. Reproducibility of orthostatic hypotension in symptomatic elderly. Am J Med. 1996;100:418422.[Medline] [Order article via Infotrieve]
52. Lipsitz LA. Orthostatic hypotension in the elderly. N Engl J Med. 1989;321:952957.[Medline] [Order article via Infotrieve]
53. Frey MAB, Tomaselli CM, Hoffler WG. Cardiovascular responses to postural changes: differences with age for women and men. J Clin Pharmacol. 1994;34:394402.[Abstract]
54. Claus JJ, Breteler MMB, Hasan D, Krenning EP, Bots ML, Grobbee DE, van Swieten JC, van Harskamp F, Hofman A. Vascular risk factors, atherosclerosis, cerebral white matter lesions and cerebral perfusion in a population-based study. Eur J Nucl Med. 1996;23:675682.[Medline] [Order article via Infotrieve]
55.
Levine BD, Giller CA, Lane LD, Buckey JC, Blomqvist G.
Cerebral versus systemic hemodynamics during graded
orthostatic stress in humans. Circulation. 1994;90:298306.
56.
Ooi WL, Barrett S, Hossain M, Kelley-Gagnon M, Lipsitz
LA. Patterns of orthostatic blood pressure change and their
clinical correlates in a frail, elderly population. JAMA. 1997;277:12991304.
57.
Rutan GH, Hermanson B, Bild DE, Kittner SJ, LaBaw F,
Tell GS. Orthostatic hypotension in older adults: the
Cardiovascular Health Study. Hypertension. 1992;19:508519.
58. Mo R, Omvik P, Lund-Johansen P. The Bergen Blood Pressure Study: estimated prevalence of postural hypotension is influenced by the alerting reaction to blood pressure measurement. J Hum Hypertens. 1994;8:171176.[Medline] [Order article via Infotrieve]
59. Applegate WB, Davis BR, Black HR, Smith WM, Miller ST, Burlando AJ. Prevalence of postural hypotension at baseline in the Systolic Hypertension in the Elderly Program (SHEP) cohort. J Am Geriatr Soc. 1991;39:10571064.[Medline] [Order article via Infotrieve]
This article has been cited by other articles:
![]() |
J. Cooke, S. Carew, M. O'Connor, A. Costelloe, T. Sheehy, and D. Lyons Sitting and standing blood pressure measurements are not accurate for the diagnosis of orthostatic hypotension QJM, May 1, 2009; 102(5): 335 - 339. [Abstract] [Full Text] [PDF] |
||||
![]() |
D Gupta and M D Nair Neurogenic orthostatic hypotension: chasing "the fall" Postgrad. Med. J., January 1, 2008; 84(987): 6 - 14. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. E Naschitz and I. Rosner Orthostatic hypotension: framework of the syndrome Postgrad. Med. J., September 1, 2007; 83(983): 568 - 574. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. M. Rose, M. L. Eigenbrodt, R. L. Biga, D. J. Couper, K. C. Light, A. R. Sharrett, and G. Heiss Orthostatic Hypotension Predicts Mortality in Middle-Aged Adults: The Atherosclerosis Risk in Communities (ARIC) Study Circulation, August 15, 2006; 114(7): 630 - 636. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. C. M. Vloet, R. E. Pel-Little, P. A. F. Jansen, and R. W. M. M. Jansen High Prevalence of Postprandial and Orthostatic Hypotension Among Geriatric Patients Admitted to Dutch Hospitals J. Gerontol. A Biol. Sci. Med. Sci., October 1, 2005; 60(10): 1271 - 1277. [Abstract] [Full Text] [PDF] |
||||
![]() |
H.-K. Kuo, F. Sorond, I. Iloputaife, M. Gagnon, W. Milberg, and L. A. Lipsitz Effect of Blood Pressure on Cognitive Functions in Elderly Persons J. Gerontol. A Biol. Sci. Med. Sci., November 1, 2004; 59(11): 1191 - 1194. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Schneeloch, G. Mies, H.-J. Busch, I. R. Buschmann, and K.-A. Hossmann Granulocyte-macrophage colony-stimulating factor-induced arteriogenesis reduces energy failure in hemodynamic stroke PNAS, August 24, 2004; 101(34): 12730 - 12735. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. E. North, K. M. Rose, I. B. Borecki, A. Oberman, S. C. Hunt, M. B. Miller, J. Blangero, L. Almasy, and J. S. Pankow Evidence for a Gene on Chromosome 13 Influencing Postural Systolic Blood Pressure Change and Body Mass Index Hypertension, April 1, 2004; 43(4): 780 - 784. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. B. Harrap, J. S. Cui, Z. Y. H. Wong, and J. L. Hopper Familial and Genomic Analyses of Postural Changes in Systolic and Diastolic Blood Pressure Hypertension, March 1, 2004; 43(3): 586 - 591. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Weiss, E. Grossman, Y. Beloosesky, and J. Grinblat Orthostatic Hypotension in Acute Geriatric Ward: Is It a Consistent Finding? Arch Intern Med, November 11, 2002; 162(20): 2369 - 2374. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Kario, K. Eguchi, S. Hoshide, Y. Hoshide, Y. Umeda, T. Mitsuhashi, and K. Shimada U-curve relationship between orthostatic blood pressure change and silent cerebrovascular disease in elderly hypertensives: Orthostatic hypertension as a new cardiovascular risk factor J. Am. Coll. Cardiol., July 3, 2002; 40(1): 133 - 141. [Abstract] [Full Text] [PDF] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
Stroke Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 2000 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |